Connection

Avtar Singh to Mice

This is a "connection" page, showing publications Avtar Singh has written about Mice.
Connection Strength

0.917
  1. Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease. Biochim Biophys Acta. 2010 Jul-Aug; 1802(7-8):601-8.
    View in: PubMed
    Score: 0.149
  2. Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI. J Neurosci Res. 2018 12; 96(12):1900-1913.
    View in: PubMed
    Score: 0.066
  3. Pathology of nNOS-Expressing GABAergic Neurons in Mouse Model of Alzheimer's Disease. Neuroscience. 2018 08 01; 384:41-53.
    View in: PubMed
    Score: 0.065
  4. GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1a. Behav Brain Res. 2018 03 15; 340:63-70.
    View in: PubMed
    Score: 0.058
  5. Effect of vitamin D3 intake on the onset of disease in a murine model of human Krabbe disease. J Neurosci Res. 2015 Jan; 93(1):28-42.
    View in: PubMed
    Score: 0.051
  6. Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion. J Alzheimers Dis. 2013; 34(3):621-35.
    View in: PubMed
    Score: 0.045
  7. Psychosine-induced alterations in peroxisomes of twitcher mouse liver. Arch Biochem Biophys. 2008 Sep 15; 477(2):211-8.
    View in: PubMed
    Score: 0.033
  8. Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. J Neurochem. 2008 May; 105(3):956-70.
    View in: PubMed
    Score: 0.032
  9. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Glia. 2007 Jan 01; 55(1):65-77.
    View in: PubMed
    Score: 0.030
  10. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction. J Neurosci Res. 2006 Aug 15; 84(3):614-25.
    View in: PubMed
    Score: 0.029
  11. IL-4-induced peroxisome proliferator-activated receptor gamma activation inhibits NF-kappaB trans activation in central nervous system (CNS) glial cells and protects oligodendrocyte progenitors under neuroinflammatory disease conditions: implication for CNS-demyelinating diseases. J Immunol. 2006 Apr 01; 176(7):4385-98.
    View in: PubMed
    Score: 0.028
  12. Dysfunction of peroxisomes in twitcher mice brain: a possible mechanism of psychosine-induced disease. Biochem Biophys Res Commun. 2006 Apr 28; 343(1):229-38.
    View in: PubMed
    Score: 0.028
  13. Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial-monocyte cell interaction. J Neurochem. 2005 Jul; 94(1):204-14.
    View in: PubMed
    Score: 0.027
  14. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease. J Neurosci Res. 2005 Jun 15; 80(6):845-54.
    View in: PubMed
    Score: 0.027
  15. Vascular and immunopathological role of Asymmetric Dimethylarginine (ADMA) in Experimental Autoimmune Encephalomyelitis. Immunology. 2021 11; 164(3):602-616.
    View in: PubMed
    Score: 0.020
  16. Regulation of B cell functions by S-nitrosoglutathione in the EAE model. Redox Biol. 2021 09; 45:102053.
    View in: PubMed
    Score: 0.020
  17. GSNOR and ALDH2 alleviate traumatic spinal cord injury. Brain Res. 2021 05 01; 1758:147335.
    View in: PubMed
    Score: 0.020
  18. Detoxification of Reactive Aldehydes by Alda-1 Treatment Ameliorates Experimental Autoimmune Encephalomyelitis in Mice. Neuroscience. 2021 03 15; 458:31-42.
    View in: PubMed
    Score: 0.020
  19. Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke. Brain Res. 2020 08 15; 1741:146879.
    View in: PubMed
    Score: 0.019
  20. Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology. FASEB J. 2020 05; 34(5):6808-6823.
    View in: PubMed
    Score: 0.019
  21. Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione. Immunobiology. 2018 10; 223(10):549-554.
    View in: PubMed
    Score: 0.016
  22. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis. Free Radic Biol Med. 2018 06; 121:57-68.
    View in: PubMed
    Score: 0.016
  23. Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model. Immunology. 2018 07; 154(3):434-451.
    View in: PubMed
    Score: 0.016
  24. Regulation of STAT3 and NF-?B activations by S-nitrosylation in multiple myeloma. Free Radic Biol Med. 2017 05; 106:245-253.
    View in: PubMed
    Score: 0.015
  25. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Redox Biol. 2015 Dec; 6:41-50.
    View in: PubMed
    Score: 0.013
  26. STAT3 regulation by S-nitrosylation: implication for inflammatory disease. Antioxid Redox Signal. 2014 Jun 01; 20(16):2514-27.
    View in: PubMed
    Score: 0.012
  27. Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-a-dependent mechanism. Glia. 2013 Sep; 61(9):1500-1517.
    View in: PubMed
    Score: 0.012
  28. T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology. 2006 Jul; 118(3):384-91.
    View in: PubMed
    Score: 0.007
  29. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem. 2005 Nov 25; 280(47):39582-93.
    View in: PubMed
    Score: 0.007
  30. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol. 2005 Jul 01; 175(1):566-74.
    View in: PubMed
    Score: 0.007
  31. S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab. 2005 Feb; 25(2):177-92.
    View in: PubMed
    Score: 0.006
  32. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol. 2004 Jan 15; 172(2):1273-86.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.